Your session is about to expire
← Back to Search
Ultrasound Imaging
Prospective Observational for Aortic Valve Disease
N/A
Waitlist Available
Research Sponsored by Philips Clinical & Medical Affairs Global
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up procedure through 48 hours or discharge, whichever is earlier
Awards & highlights
Summary
The purpose of this observational registry is to report real-world safety and performance of VeriSight for ultrasound guided ICE imaging in percutaneous cardiac intervention procedures when used in standard clinical practice.
Eligible Conditions
- Aortic Valve Disease
- Aortic Valve Stenosis
- Tricuspid Valve Disease
- Patent Foramen Ovale
- Atrial Septal Defect
- Mitral Valve Disease
- Atrial Fibrillation
- Stroke
- Valvular Heart Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during procedure
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Clinical Success
Device-related adverse event detection
Imaging Success
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Prospective ObservationalExperimental Treatment1 Intervention
Prospective observational subjects undergoing planned cardiac procedures utilizing image guidance
Find a Location
Who is running the clinical trial?
Philips Clinical & Medical Affairs GlobalLead Sponsor
53 Previous Clinical Trials
16,745 Total Patients Enrolled
Rashmi Ram, PhDStudy DirectorPhilips Clinical and Medical Affairs
Share this study with friends
Copy Link
Messenger